Provider review
Tomorrow review
By The Dose Brief Desk · Updated
Tomorrow publishes monthly and quarterly compound prices and names its clinical and pharmacy partners. Its early order-cancellation cutoff deserves as much attention as the headline price.
Not rated. This review examines published program information; it is not a firsthand treatment review.
At a glance
- Semaglutide
- $199 monthly; $549 billed every three months
- Tirzepatide
- $299 monthly; $819 billed every three months
- Availability
- Advertises clinicians licensed in all 50 states; confirm treatment and pharmacy eligibility for your location.
- Treatment formats
- Compounded injections and sublingual drops; separately priced branded Wegovy and Zepbound.
Cancel future billing at least three days ahead; an order submitted for medical review cannot be canceled under the refund policy.
Compare the payment, not just the monthly equivalent
The standard compounded semaglutide injection costs $199 on a monthly plan or $549 charged every three months. Tirzepatide costs $299 monthly or $819 every three months. The lower $183 and $273 monthly equivalents therefore require a larger quarterly payment. The product pages include medication, clinical review, ongoing oversight, shipping and injection supplies where applicable.
Tomorrow also sells lower-priced microdose programs. Those are separate offers, so their prices should not replace the standard injection prices in a weight-loss comparison. Ask which product, supply and renewal schedule appear on your own order.
Drops and brand-name products are different offers
Sublingual semaglutide and tirzepatide list the same monthly and quarterly prices as the corresponding compounded injections. A shared ingredient or price does not make these formulations interchangeable. The brand pages separately list Wegovy at $1,699 monthly and Zepbound at $1,399 monthly; these are Tomorrow’s advertised offers, not universal manufacturer prices.
Named partners make the care arrangement easier to check
Tomorrow identifies Tomorrow Health LLC as the platform operator and Arora Health & Aesthetics, LLC as an independent medical group. Its care page names VialsRX for compounded injectables and The Pharmacy Hub for sublingual and branded products. Confirm the actual prescribing clinician and dispensing pharmacy on your prescription; a published partner list does not independently verify an individual prescription.
The cancellation clock starts before shipping
The refund policy says an order cannot be canceled once it has been submitted for medical review, even before dispensing. Separately, the cancellation policy requires at least three days of notice before the next billing date and excludes refunds for processed charges or partly used subscription periods. If you want to stop, distinguish the current order from future renewals and retain the written confirmation.
What stands out
- Public monthly and quarterly totals
- Names the medical group and dispensing partners
What to check
- Quarterly rate requires a larger upfront charge
- Current-order cancellation closes at medical review
Sources and review scope
Public information checked in October 2026. Prices and eligibility can change. We have not enrolled in treatment, independently tested medications or verified the licenses of the clinicians and pharmacies involved in an individual prescription. Compounded medications are not FDA-approved; studies of approved brands do not establish that a compounded product has the same safety or effectiveness.
- Standard semaglutide plans (opens in a new tab)
- Standard tirzepatide plans (opens in a new tab)
- Clinical and pharmacy partners (opens in a new tab)
- Sublingual semaglutide (opens in a new tab)
- Sublingual tirzepatide (opens in a new tab)
- Wegovy offer (opens in a new tab)
- Zepbound offer (opens in a new tab)
- Refund policy (opens in a new tab)
- Cancellation policy (opens in a new tab)